C. KÖSE Et Al. , "Predictive Utility of Systemic Immune Inflammation Index (SII) in Identifying Endometrial Carcinoma in Premalignant Endometrial Lesions," Van Tıp Dergisi , vol.30, no.4, pp.418-425, 2023
KÖSE, C. Et Al. 2023. Predictive Utility of Systemic Immune Inflammation Index (SII) in Identifying Endometrial Carcinoma in Premalignant Endometrial Lesions. Van Tıp Dergisi , vol.30, no.4 , 418-425.
KÖSE, C., KÖRPE, B., KURDOĞLU, Z., KORKMAZ, H., ÜSTÜN, Y., & KORKMAZ, V., (2023). Predictive Utility of Systemic Immune Inflammation Index (SII) in Identifying Endometrial Carcinoma in Premalignant Endometrial Lesions. Van Tıp Dergisi , vol.30, no.4, 418-425.
KÖSE, CANER Et Al. "Predictive Utility of Systemic Immune Inflammation Index (SII) in Identifying Endometrial Carcinoma in Premalignant Endometrial Lesions," Van Tıp Dergisi , vol.30, no.4, 418-425, 2023
KÖSE, CANER Et Al. "Predictive Utility of Systemic Immune Inflammation Index (SII) in Identifying Endometrial Carcinoma in Premalignant Endometrial Lesions." Van Tıp Dergisi , vol.30, no.4, pp.418-425, 2023
KÖSE, C. Et Al. (2023) . "Predictive Utility of Systemic Immune Inflammation Index (SII) in Identifying Endometrial Carcinoma in Premalignant Endometrial Lesions." Van Tıp Dergisi , vol.30, no.4, pp.418-425.
@article{article, author={CANER KÖSE Et Al. }, title={Predictive Utility of Systemic Immune Inflammation Index (SII) in Identifying Endometrial Carcinoma in Premalignant Endometrial Lesions}, journal={Van Tıp Dergisi}, year=2023, pages={418-425} }